Technology | Enterprise Imaging | January 23, 2017

Carestream Shows Zero-Footprint Enterprise Imaging Platform at HIMSS 2017

Platform can enable affordable new applications by streamlining deployment and interoperability, imaging analytics designed to improve decision support

January 23, 2017 — Carestream Health will demonstrate a zero-footprint enterprise imaging platform that can easily enable new use cases and modules at the upcoming Healthcare Information and Management Systems Society (HIMSS) conference, Feb. 19-23 in Orlando, Fla.

Leveraging the latest interoperability standards such as FHIR, IHE-IOCM and IHE-XDS, the Carestream Clinical Collaboration Platform is future-proof by consolidating legacy proprietary systems as well as forming the foundation for advanced imaging analytics services. The company’s powerful enterprise image data management solution makes patients’ clinical data and images available to physicians and other stakeholders.

The Unified Core architecture is the heart of Carestream’s Clinical Collaboration Platform that delivers solutions to help manage enterprise workflow, consolidate silos of data, and facilitate diagnostic reading and image sharing as well as imaging analytics. Unified Core is a common set of codes and a development process that streamlines resource management, security and interoperability and manages clinical data such as DICOM, photos, videos, ECGs, continuity of care documents and scanned documents.

Since the platform is delivered via zero-footprint technology, healthcare providers can choose the right modules within the platform to address specific strategic needs such as: image-enabling the electronic medical record (EMR) for universal physician access; offering a new telemedicine model using remote order/entry; consolidating archives with intelligent image lifecycle management; and supporting regional image exchange and patient engagement.

Carestream also will showcase a work-in-progress, real-time analytics module designed to offer better decision support at the time of diagnosis to help reduce errors and improve quality. This module will offer report-based and image-based analytics using machine learning and natural language processing and is designed to: find errors and discrepancies in reports; conduct semantic searches; provide interpretation support for difficult cases; collect data for population health; and provide input for research projects.

For more information: www.carestream.com

Related Content

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation.

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation. Higher signal intensity can be seen in the central white matter, particularly for the 31-week gestation infant. The bottom panels display the corresponding slices with objectively segmented DWMA in yellow. The 27-week infant (left) was diagnosed with mild DWMA, the 26-week infant (center) was diagnosed with moderate DWMA, and the 31-week infant had severe DWMA. Image courtesy of Cincinnati Children's and Nature Scientific Reports

News | Magnetic Resonance Imaging (MRI) | October 01, 2020
October 1, 2020 — As many as 70% of very premature infants (born earlier than 32 weeks gestation) show signs of white
Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
News | SPECT Imaging | September 30, 2020
September 30, 2020 — Siemens Healthineers h
Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions
News | Artificial Intelligence | September 25, 2020
September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...